Skip to content

HHRI News & Press Releases

HHRI News & Press Releases

Hennepin Healthcare partners with University of Minnesota on COVID-19 clinical trials of blood pressure drug losartan

April 20, 2020

Hennepin Healthcare Research Institute (HHRI) and University of Minnesota Medical School researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19. Both studies are multi-site trials, one for patients requiring hospitalization and the other…

Read More

Hennepin Healthcare launches two clinical trials to study the investigational antiviral drug remdesivir to treat hospitalized patients with COVID-19

April 9, 2020

Minneapolis, Minn. – April 9, 2020 – The Hennepin Healthcare Research Institute (HHRI) has launched two clinical trials to study the safety and efficacy of remdesivir to treat hospitalized patients diagnosed with moderate or severe COVID-19, the disease caused by the novel coronavirus SARS-CoV-2.  Hennepin Healthcare is a clinical site…

Read More
input search string and hit enter